SERPINB2 and breast carcinoma: SerpinB2 function remains paradoxical in breast cancer; SerpinB2 is associated with reduced metastasis and prolonged survival in patients with breast cancer [29, 30] and shows increased significance for a favorable prognosis [31–33].